iMTSS: an integrated framework for biology- and patient-driven prognosis in myelofibrosis undergoing transplantation.
Relapse and non-relapse mortality after transplantation for myelofibrosis are governed by distinct dimensions, and estimating both outcomes independently with genetic and clinical information, in addition to overall survival, establishes an individualized basis for transplant decision-making.